Dyne Therapeutics Presents Nonhuman Primate Proof of Concept Data on FORCE™ Therapeutic Platform at International Myotonic Dystrophy Consortium Meeting (IDMC-12)
Data demonstrates clinically relevant levels of gene knockdown in nonhuman primates with a single dose of Dyne-102 Company is developing…